Cargando…

Antipsychotic Polypharmacy in Treatment of Schizophrenia; Should or Should Not?

Antipsychotics have been utilized as the standard treatment for schizophrenia regardless of illness phase where antipsychotic monotherapy (APM) is routinely recommended as the gold standard rather than antipsychotic polypharmacy (APP). However, approximately 20 to 40% of patients with schizophrenia...

Descripción completa

Detalles Bibliográficos
Autor principal: Pae, Chi-Un
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chonnam National University Medical School 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520369/
https://www.ncbi.nlm.nih.gov/pubmed/33014754
http://dx.doi.org/10.4068/cmj.2020.56.3.157